the aid library

LIST OPTIONS

Filter

919

Sort by:

Direction:

Download (125)

View PDF (130)

COVID-19: How to include marginalized and vulnerable people in risk communication and community engagement

Inter-Agency Standing Committee IASC; World Health Organization (WHO); UNICEF; et al. (2020) C1

Women, the elderly, adolescents, youth, and children, persons with disabilities, indigenous populations, refugees, migrants, and minorities experience the highest degree of socio-economic marginalization. Marginalized people become even more vulnerable in emergencies.1 This is due to factors su... more

Download (124)

View PDF (179)

Policy Brief: COVID-19 and the Need for Action on Mental Health (13 May 2020)

United Nations (2020) CC

Although the COVID-19 crisis is, in the first instance, a physical health crisis, it has the seeds of a major mental health crisis as well, if action is not taken. Good mental health is critical to the functioning of society at the best of times. It must be front and centre of every country’s resp... more

Download (122)

View PDF (125)

COVID-19: Chloroquine and hydroxychloroquine research

World Health Organization WHO (2020) C_WHO

This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri... more

Download (93)

View PDF (129)

Situational Brief: Covid-19 and associated risks for Central Asian temporary labour migrants in the Russian Federation

King E. J., N. Zotova Lancet Migration (2020) CC

The Russian Federation continues to be a major destination country for Central Asianlabour migrants. There were nearly million Central Asians living in the Russian Federation in 2019, mainly coming from Kyrgyzstan, Tajikistan, and Uzbekistan in order to seek employment opportunities. Men continue to... more

Download (84)

View PDF (128)

COVID-19 in children and the role of school settings in COVID-19 transmission- first update

European Centre for Disease Prevention and Control ECDC (2020) C1

23 Dec 2020. The aim of this document is to provide an update on the knowledge surrounding the role of children in the transmission of SARS-CoV-2 and the role of schools in the COVID-19 pandemic, based on the experience in the EU from August–December, 2020. This document also addresses transmissio... more

Download (122)

View PDF (158)

Standard Operating Procedure: COVID-19 Antenatal, Intrapartum, Postpartum and Obstetric Emergency Care

World Health Organization WHO, Save the Children; Health Sector Cox Bazar; et al. (2020) C_WHO

Forcibly Displaced Myanmar National / Rohingya Refugee Response. This document gives guidance for medical providers to understand the care of both healthy and COVID suspect or confirmed patients who present for antenatal (ANC), intrapartum (IP), postnatal (PNC), or emergency obstetric and neonatal ... more

Download (89)

View PDF (108)

Moldova: COVID-19 - Socio-Economic Response and Recovery Plan – June 2020

United Nations in Moldova (2020) C1

Download (91)

View PDF (136)

Under Siege - Impact of COVID-19 on Girls in Africa

ACPF, Plan International (2020) CC

The COVID-19 pandemic has exacerbated and added yet another layer of vulnerability to an already dire web of vulnerabilities of girls in the African continent, which constitute about 49% of the total child population. Critically, gender equality and girls’ multidimensional vulnerability have been ... more

Download (133)

View PDF (157)

Yemen: COVID-19 Preparedness and Response Monthly Report (January 2021)

Office for the Coordination of Humanitarian Affairs OCHA (2021) CC

Download (76)

View PDF (124)

Framework for Fair, Equitable and Timely Allocation of COVID-19 Vaccines in Africa. Highlights Day 1

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1

The virtual conference, co-organised by the Africa Centres for Disease Control and Prevention (Africa CDC) and the South African Medical Research Council (SAMRC) brought together African leaders, public health professionals and researchers, policymakers, business leaders and civil society and commun... more

Download (74)

View PDF (133)

Analysing and using routine data to monitor the effects of COVID-19 on essential health services: practical guide for national and subnational decision-makers

World Health Organization WHO (2021) C_WHO

14 January 2021 This practical guide can be used to help countries monitor and analyse the impact of COVID-19 on essential health services to inform planning and decision-making. It provides practical recommendations on how to use key performance indicators to analyse changes in access to and deliv... more

Download (151)

View PDF (156)

Health system considerations: when influenza meets COVID-19: preparedness and response measures when COVID-19, influenza and acute respiratory infections coincide in the WHO European Region

World Health Organization WHO, Regional Office of Europe (2020) C_WHO

revised version December 2020

Download (104)

View PDF (141)

COVID-19 home care bundle for health care workers

World Health Organization WHO (2021) C_WHO

7 May 2021

Download (89)

View PDF (124)

Health Sector Strategic Preparedness and Response Plan for COVID-19

World Health Organization WHO; Health Sector Syria (2021) C_WHO

Revised

Download (82)

View PDF (121)

COVID-19 disease in children and adolescents: Scientific brief, 29 September 2021/ مرض كوفيد -19 لدى الأطفال والمراهقين (Arabic Version)

World Health Organization WHO (2021) C_WHO

SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch... more

Download (79)

View PDF (409)

Effect of COVID-19 pandemic on provision of sexual and reproductive health services in primary health facilities in Nigeria: a cross-sectional study

Adelekan, B.; E. Goldson, Z. Abubakar et al. Repoductive Health Journal (2021) CC

RESULTS: Between 76 and 97% of the PHCS offered RMCAH services before the lockdown. Except in antenatal, delivery and adolescent care, there was a decline of between 2 and 6% in all the services during the lockdown and up to 10% decline after the lockdown with variation across and within States. Dur... more

Download (160)

View PDF (165)

Integrated Wash, Health And Protection Response To Covid-19 In West And East Hararghe Zones Of Oromia Region, Ethiopia

CARE; USAID (2022) CC

East and West Hararghe zones are located within Oromia region, one of the largest and most populated regions of Ethiopia. Like many parts of Oromia and the country, over 80% of the people in East and West Hararghe rely on agricultural livelihoods. This baseline survey target districts are Babile, an... more

Download (92)

View PDF (109)

Gender and race: Experiences of health workers in Brazil during COVID-19

Tan, H.-L. and K. Hawkins (2022) C1

Brazil ́s response is taking place in strict compliance with the International Health Regulations (IHR) 2005. Brazil created the Emergency Operations Center (COE) and immediately notified WHO when the first case in Brazilian territory was confirmed on February 26.

Download (126)

View PDF (193)

Africaʼs response to the COVID-19 pandemic. A summary of country reports

World Health Organization WHO, Regional Office of Africa (2022) C_WHO

January 2020 to December 2021

Download (245)

View PDF (330)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more